|Bid||56.10 x 900|
|Ask||57.10 x 900|
|Day's range||56.07 - 57.08|
|52-week range||46.48 - 64.21|
|Beta (5Y monthly)||0.15|
|PE ratio (TTM)||104.49|
|Forward dividend & yield||1.40 (2.47%)|
|Ex-dividend date||12 Aug 2021|
|1y target est||69.28|
Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. Shares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the S&P 500 has soared by more than 5%. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine.
Stifel Chief Equity Strategist Barry Bannister joins Yahoo Finance Live to discuss the investor implications of a newly discovered COVID-19 variant as we enter the second winter of the pandemic.
BJ's Wholesale and AstraZeneca have been highlighted as Zacks Bull and Bear of the Day